Tuberous Sclerosis: How CBD Can Help
What happens when a complex genetic mutation leads to epilepsy? A study conducted by Hess, Thiele, and their team, published in the journal Epilepsia in 2016, transformed the treatment of Tuberous Sclerosis Complex (TSC), one of the most challenging areas in modern neurology.
The Challenge of Tuberous Sclerosis
TSC is a rare genetic disorder characterized by the growth of benign tumors in vital organs, particularly the brain. The statistics are concerning: 85% of individuals with TSC develop epilepsy, and 63% of these patients experience seizures that do not respond to standard medications. This resistance to treatment significantly impacts their quality of life.
A Year-Long Study
Dr. Elizabeth Thiele led a study that monitored patients for an entire year, in contrast to many short-term trials. This long-term perspective is crucial as it demonstrates that CBD can offer a sustainable treatment solution, not just a temporary fix.
What Was The Dosing Protocol?
The study adhered to a precise dosing regimen:
- Initial dose: 5 mg/kg/day
- Maximum dose: Up to 50 mg/kg/day
These doses are considerably higher than those typically used for treating anxiety or sleep disorders, indicating that CBD can be safe even at the elevated levels required for serious conditions.
Study Results: Fewer Seizures
The findings from Thiele's team revealed:
- Seizures were reduced by 48.8% after three months of treatment.
- Improvement remained consistent at the one-year mark, with no evidence of diminished effectiveness over time.
- Although some patients experienced side effects such as diarrhea, drowsiness, and reduced appetite, the majority of effects were mild to moderate and did not necessitate discontinuation of treatment.
CBD in Neurology
The results from Dr. Thiele's team represent a significant advancement in the treatment of genetic epilepsy. The FDA approved purified cannabidiol in 2020, and the EMA followed suit in 2021, officially recognizing it as a treatment for Tuberous Sclerosis Complex.
This success story illustrates that CBD, when used under appropriate medical supervision and in accordance with established dosing guidelines, can be a viable option for patients struggling with traditional medications. Including CBD in clinical guidelines marks a major shift in modern neurology, with cannabinoid treatments now accepted as part of the management of complex seizure disorders.
More From Soft Secrets:
CBD May Help Overcome Drug Resistance in Leukaemia Treatment
CBD: Potentially Effective Against Antibiotic-Resistant Bacteria
L
Liz Filmer
